Skip to main content Accessibility help
×
Home
Hostname: page-component-747cfc64b6-zm8ws Total loading time: 0.15 Render date: 2021-06-16T15:45:27.942Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "metricsAbstractViews": false, "figures": true, "newCiteModal": false, "newCitedByModal": true, "newEcommerce": true }

Negative Tuberculin Skin Test and Prediction of Reversion of QuantiFERON Interferon Gamma Release Assay in US Healthcare Workers

Published online by Cambridge University Press:  28 January 2016

Wendy Thanassi
Affiliation:
Occupational Health Service, Veterans Affairs Health Care System, Palo Alto, California Occupational Health Strategic Health Care Group, Office of Public Health, Veterans Health Administration, Washington, DC Department of Internal Medicine, Stanford University School of Medicine, Stanford, California
Art Noda
Affiliation:
War Related Illness and Injury Study Center and Mental Illness Research Education and Clinical Center, Department of Veterans Affairs, Palo Alto, California Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California
Beatriz Hernandez
Affiliation:
War Related Illness and Injury Study Center and Mental Illness Research Education and Clinical Center, Department of Veterans Affairs, Palo Alto, California Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California
Leah Friedman
Affiliation:
War Related Illness and Injury Study Center and Mental Illness Research Education and Clinical Center, Department of Veterans Affairs, Palo Alto, California Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California
Susan Dorman
Affiliation:
Johns Hopkins University School of Medicine, Baltimore, Maryland.
Jerome Yesavage
Affiliation:
War Related Illness and Injury Study Center and Mental Illness Research Education and Clinical Center, Department of Veterans Affairs, Palo Alto, California Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California
Corresponding
E-mail address:

Abstract

QuantiFERON tuberculosis tests (QFT) reverted in (612) 77% of 1,094 low-risk healthcare workers (HCW) testing less than 1.16 IU/mL. Of HCW testing greater than 1.1 IU/mL, 33 (59%) of 56 with negative tuberculin skin tests (TST) reverted vs 8 (6%) of 125 with positive TSTs. Retesting low-risk QFT-positive and TST-negative HCW is prudent.

Infect. Control Hosp. Epidemiol. 2016;37(4):478–482

Type
Concise Communications
Copyright
© 2016 by The Society for Healthcare Epidemiology of America. All rights reserved 

Access options

Get access to the full version of this content by using one of the access options below.

References

1. Dorman, SE, Belknap, R, Graviss, EA, et al. Interferon-γ release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States. Am J Respir Crit Care Med 2013;189:7787.Google ScholarPubMed
2. Thanassi, W, Noda, A, Hernandez, B, et al. Delineating a retesting zone using receiver operating characteristic analysis on serial QuantiFERON tuberculosis test results in US healthcare workers. Pulm Med 2012;2012:291294.CrossRefGoogle ScholarPubMed
3. Mori, T, Sakatani, M, Yamagishi, F, et al. Specific detection of tuberculosis infection. Am J Respir Crit Care Med 2004;170:5964.CrossRefGoogle ScholarPubMed
4. Whitworth, WC, Hamilton, LR, Goodwin, DJ, et al. Within-subject interlaboratory variability of QuantiFERON-TB Gold In-Tube tests. PLOS ONE 2012;7:e43790.CrossRefGoogle ScholarPubMed
5. Metcalfe, JZ, Cattamanchi, A, McCulloch, CE, Lew, JD, Ha, NP, Graviss, EA. Test variability of the QuantiFERON-TB Gold In-Tube assay in clinical practice. Am J Respir Crit Care Med 2013;187:206211.CrossRefGoogle ScholarPubMed
6. Doberne, D, Gaur, RL, Banaei, N. Preanalytical delay reduces sensitivity of QuantiFERON-TB Gold In-Tube assay for detection of latent tuberculosis infection. J Clin Microbiol 2011;49:30613064.CrossRefGoogle ScholarPubMed
7. QuantiFERON-TB Gold (in-tube method). Hilden, Germany: Qiagen/Cellestis, US05990301K ed; 2011.Google Scholar
8. Yesavage, JK. Signal detection software for receiver operator characteristics (ROC), version 4. 22. Stanford University website. http://web.stanford.edu/~yesavage/ROC.html. Published 2007. Accessed May 14, 2014.Google Scholar
9. Behrman, AB, Budnick, W, Hodgson, L, et al. Protecting health care workers from tuberculosis, 2013. J Occup Envir Med 2013;55.CrossRefGoogle Scholar
10. Schablon, A, Nienhaus, A, Ringshausen, FC, Preisser, AM, Peters, C. Occupational screening for tuberculosis and the use of a borderline zone for interpretation of the IGRA in German healthcare workers. PLOS ONE 2014;9:e115322.CrossRefGoogle Scholar
4
Cited by

Send article to Kindle

To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Negative Tuberculin Skin Test and Prediction of Reversion of QuantiFERON Interferon Gamma Release Assay in US Healthcare Workers
Available formats
×

Send article to Dropbox

To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

Negative Tuberculin Skin Test and Prediction of Reversion of QuantiFERON Interferon Gamma Release Assay in US Healthcare Workers
Available formats
×

Send article to Google Drive

To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

Negative Tuberculin Skin Test and Prediction of Reversion of QuantiFERON Interferon Gamma Release Assay in US Healthcare Workers
Available formats
×
×

Reply to: Submit a response

Please enter your response.

Your details

Please enter a valid email address.

Conflicting interests

Do you have any conflicting interests? *